Author: News Room
Dublin, April 11, 2024 (GLOBE NEWSWIRE) — The “Global Clinical Nutrition For Cancer Care Market Size, Share & Trends Analysis Report by Product (Oral, Nutrition Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, Region, and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering.The global clinical nutrition for cancer care market size is estimated to reach USD 7.95 billion by 2030, growing at a CAGR of 5.04% during the forecast period. Advancements in medical foods for cancer care have been a significant area of focus in research and development, aiming to enhance treatment outcomes and boost the overall quality…
The Publicity Department of Gangnan District, Guigang GUIGANG, China, April 11, 2024 (GLOBE NEWSWIRE) — “The goods were shipped from overseas to Guigang and cleared customs in just eight days. This new model is 17 days faster than the traditional customs clearance via Hong Kong, significantly reducing time and economic costs!,” said Yang Chaodong, General Manager of Jialu Feather Products Co., Ltd. in Guigang. On March 28, a shipment of approximately 18.5 tons of washed white duck feathers imported by the company through Qinzhou Port passed customs inspection smoothly after joint supervision by Qinzhou Port Customs and Guigang Customs, marking…
Dublin, April 11, 2024 (GLOBE NEWSWIRE) — The “Vietnam Buy Now Pay Later Business and Investment Opportunities Databook – 75+ KPIs on BNPL Market Size, End-Use Sectors, Market Share, Product Analysis, Business Model, Demographics – Q1 2024 Update” report has been added to ResearchAndMarkets.com’s offering.BNPL payments in Vietnam are expected to grow by 41.8% on an annual basis to reach US$3.33 billion in 2024.The medium to long-term growth story of the BNPL industry in the country remains strong. BNPL payment adoption is expected to grow steadily over the forecast period, recording a CAGR of 27.6% during 2024-2029. The BNPL gross…
BARCELONA, April 11, 2024 (GLOBE NEWSWIRE) — FC Barcelona and EBC Financial Group (EBC) are pleased to announce their partnership in the foreign exchange sector across multiple regions for 3.5 years, commencing today. This partnership designates EBC as FC Barcelona’s official Partner in Foreign Exchange, with coverage extending to regions including APAC, LATAM, the Middle East, and Africa. This partnership marks a significant milestone for EBC, aligning the brand with the respected legacy and global reach of FC Barcelona. Under this exclusive agreement, EBC is granted the unique privilege to engage in specialized business activities within the foreign exchange domain.…
NEW YORK, NY, April 11, 2024 (GLOBE NEWSWIRE) — Counslr, the text-based mental health support mobile app, announced today the launch of several initiatives to address the increasing need nationwide for more accessible mental health resources for young athletes, which was recently highlighted in the NCAA Mental Health Report. The mental health text messaging app recently formulated partnerships with nonprofits focused on empowering student-athletes and supporting their well-being, and also launched Counslr Chats – a video series designed to minimize the stigma surrounding help-seeking behavior. Counslr kicked off its virtual interview series with an episode focused on student-athlete mental health,entitled…
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) — Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Catalent, Inc. (NYSE: CTLT) by Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation. Under the terms of the agreement, Catalent stockholders will receive $63.50 in cash for each share of Catalent common stock owned. If you own shares of Catalent, Inc. click here. Is the Proposed Acquisition Best for Catalent, Inc. (CTLT) and its Shareholders? On February 2, 2024, the companies announced a merger agreement…
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Shoals Technologies Group, Inc. (NASDAQ: SHLS) common stock between May 17, 2022 and November 7, 2023. Shoals purports to be a leading provider of electrical balance of system (“EBOS”) products for solar power generation, battery storage, and electric vehicle charging infrastructure. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating the Allegations that Shoals…
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired The Chemours Company (NYSE: CC) common stock between February 10, 2023 and February 28, 2024. Chemours is an industrial and specialty chemical company for a number of markets including, among others, the “coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, general industrial, and oil and gas” markets. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The…
BOSTON, April 10, 2024 (GLOBE NEWSWIRE) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released a comprehensive research report entitled Cystic Fibrosis – Global Clinical Trial Landscape. The report presents a data-backed review of the Cystic Fibrosis (CF) funding landscape, trial density and patient recruitment data across geographies, standard of care and emerging therapies, recent USFDA approvals, and regulatory trends. Importantly it also includes an in-depth SWOT analysis, to guide biotech firms on strategic decision-making, and research opportunities, and challenges.…
BOSTON, April 10, 2024 (GLOBE NEWSWIRE) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an expert report, Acute Myeloid Leukaemia – Global Clinical Trial Landscape, offering critical data-backed analysis of the latest developments in Acute Myeloid Leukemia (AML) research. The report presents a comprehensive look at the AML funding landscape, trial density, patient recruitment data across geographies, standard of care, emerging therapies, recent USFDA approvals, and regulatory trends. Importantly it also includes an in-depth SWOT analysis to guide strategic…